The linked FDA records identify Kossel Medtech (Suzhou) Co., Ltd. as the applicant on two traditional 510(k) submissions reviewed by the Cardiovascular panel. The Giranel Guiding Sheath Set, K262674, was received July 30, 2026 and decided October 15, 2026; the NC PTA Balloon Dilatation Catheter, K254212, was received December 29, 2025 and decided September 16, 2026. Both carry the decision code SESE, described by FDA as Substantially Equivalent, and both list a Summary rather than a statement. The filing address is Building 6, No. 8 Jinfeng Road, Suzhou New District, 215163, China. [1][2][3][4]

Two cleared cardiovascular devices

K262674 covers the Giranel Guiding Sheath Set under product code DYB, mapped in FDA's classification data to 21 CFR 870.1340 with the device name "Introducer, Catheter" and device class 2. The submission was Traditional, not reviewed by a third party, and not a combination product; the record shows no authorized predetermined change control plan. K254212 covers the NC PTA Balloon Dilatation Catheter under product code LIT, classified as "Catheter, Angioplasty, Peripheral, Transluminal" at 21 CFR 870.1250, device class 2. [1][2][3][8]

The K254212 summary describes a two-lumen catheter, one lumen used for a stated purpose, with nominal pressures noted in the source as 6 atm for the ø12.0–ø18.0 mm sizes and 6 atm for the ø20.0–ø26.0 mm sizes. The same summary states the device is intended to dilate lesions in large vessels and that differences between the subject device and the predicate and reference devices do not raise new questions of safety or effectiveness. [4]

Giranel construction as published

Kossel's own press release states that the Giranel Guiding Sheath Set has a dual stiffness shaft construction with a soft distal tip, a hydrophilic coating, an inner lumen PTFE coating and stainless steel spring coil reinforcement. The same release says the product holds NMPA certification and EU CE-MDR certification alongside the FDA clearance, and describes the FDA action as the third major market regulatory approval for the product. These are the publisher's statements about its own product. [7]

Kossel's product listing names Giranel™ Guiding Sheath among its peripheral offerings, alongside Falspeed® PTA Balloon Dilatation Catheter, Falexpand® HP PTA Balloon Dilatation Catheter, Sabelly® LD PTA Balloon Dilatation Catheter, Octoparms® Vena Cava Filter and Swanec® Vena Cava Filter Retrieval Set. The coronary list includes MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System, Selethru® PTCA and NC PTCA balloon dilatation catheters, Selebrek® CTO Balloon Catheter, Selepump® Inflation Device, Selestem® Radial Artery Tourniquet and Misatin® Hydrophilic Guidewire. [6]

Company scope and partnership

Kossel's site organizes activity into coronary, peripheral, electrophysiology and contract service lines, with the peripheral description covering PTA balloon catheters used for limb blood vessels and extended to arteries such as the renal artery. The company describes a technical team and production line for developing and producing stents. An August 25, 2026 announcement states that Kossel and InnoMed entered a strategic partnership for global commercialization of a Python DCB, described as exclusive overseas distribution plus technical cooperation. [5][9]

The public information does not establish ownership, parentage, headquarters, customer relationships, sales volumes or independent clinical performance for Kossel. The Suzhou address appears in FDA filings and in the company's published contact details; it is a filing and contact address, not a verified headquarters designation. [1][2][5]

What the collection shows

The supplied portfolio snapshot, retrieved November 20, 2026, links two records, both under the 510k pathway, and both with decision SESE. The smaller record sample contains the same two entries, so the sample decision count of two SESE matches the full collection count of two SESE. These are counts of supplied filings as of that retrieval, not measures of total company portfolio, sales or safety performance. No recall records appear in the supplied sample. [1][2]